Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Paradigm Biopharmaceuticals Ltd. ( (AU:PAR) ) just unveiled an update.
Paradigm Biopharmaceuticals Ltd. has announced a proposed bonus issue of securities, which includes a significant number of Loyalty and Piggyback Options. This move, scheduled for completion in early February 2025, represents a strategic effort to enhance shareholder value and potentially strengthen the company’s market position by rewarding existing investors and encouraging long-term investment.
More about Paradigm Biopharmaceuticals Ltd.
YTD Price Performance: 22.96%
Average Trading Volume: 3,620
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $134.3M
See more data about PAR stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue